SCHEMBL3610992

SCHEMBL3610992

CC(O)c1c(O)c(F)cc2c1ccn2S(=O)(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 17/20 0.49
HTR1A P08908 3/20 0.42
DRD3 P35462 3/20 0.42
HTR1D P28221 2/20 0.42
HTR1B P28222 2/20 0.42
HTR1F P30939 2/20 0.42
HTR7 P34969 2/20 0.42
DRD2 P14416 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
BRD4 O60885 1/20 0.41
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3622079 0.89 HTR6 (0.48) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL3622514 0.88 HTR6 (0.47) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL13120210 0.88 HTR6 (0.47) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL3620082 0.87 HTR6 (0.49) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL13120215 0.87 HTR6 (0.49) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL3622841 0.85 HTR6 (0.49) HTR6HTR1ADRD3HTR1DHTR1B
Trifluoroacetic Acid SCHEMBL3616515 0.82 HTR6 (0.44) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL3614178 0.81 HTR6 (0.51) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL3620237 0.80 HTR6 (0.51) HTR6HTR1ADRD3HTR1DHTR1B
SCHEMBL3620380 0.80 HTR6 (0.49) HTR6HTR1ADRD3HTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046741-B1 INDOLES AS 5-HT6 MODULATORS PROXIMAGEN LTD (GB) 2012-10-31 EP disclosed
US-7812017-B2 4-substituted indole and indoline compounds BIOVITRUM AB (PUBL.) (SE) 2010-10-12 US disclosed
CN-101484420-A Indoles as 5-HT 6 modulators BIOVITRUM AB PUBL (SE) 2009-07-15 CN disclosed
EP-2046741-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (publ) (SE) 2009-04-15 EP disclosed
US-20080032968-A1 New compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2008-02-07 US disclosed
WO-2008003703-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (PUBL) (SE) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032968-A1 New compounds HTR6, HTR1B, HTR1A HTR6 1/4885HTR1A 3/4885DRD3 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.